Heart Failure Pharm Flashcards

1
Q

What is heart failure?

A

AHA - Complex syndrome resulting from structural or functional impairment involving ventricular filling or ejection of blood

Highly lethal and incidence increasing; 5-year mortality ~50%; progressive disorder.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the primary signs and symptoms of heart failure?

A
  • Fatigue
  • Tachycardia
  • Decreased exercise tolerance
  • Shortness of breath
  • Edema (peripheral and pulmonary)
  • Enlarged Heart (Cardiomegaly)

These symptoms can vary based on the type of heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the difference between HFrEF and HFpEF?

A
  • HFrEF: Heart Failure with reduced ejection fraction (systolic HF)
  • HFpEF: Heart Failure with preserved ejection fraction (diastolic HF)

HFrEF is often due to myocardial infarction and afterload; HFpEF is due to myocardial hypertrophy and stiffening.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the common theme in heart failure?

A

Decreased cardiac output

The decrease in cardiac output triggers compensatory changes aimed at maintaining cardiac output.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are factors affecting preload?

A
  • Blood volume
  • Venous return
  • Sympathetic tone to veins
  • Atrial contraction

Preload refers to the volume of blood in the ventricles at the end of diastole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are factors affecting afterload?

A
  • Sympathetic tone to arteries (PVR)
  • Vasoconstrictor hormones
  • Pathology (vascular stiffening)

Afterload is the pressure against which the heart must work to eject blood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the role of Angiotensin Converting Enzyme Inhibitors (ACEI) in heart failure treatment?

A

Decrease afterload, aldosterone, vasopressin levels, sympathetic nerve activity, and adverse remodeling of heart, blood vessels, and kidneys

Examples include Lisinopril and Enalapril; beneficial for all patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the adverse effects of Angiotensin Converting Enzyme Inhibitors (ACEI)?

A
  • Hypotension
  • Hyperkalemia
  • Dry cough
  • Dysgeusia
  • Occasionally maculopapular rash
  • Angioedema

Generally well-tolerated but can have significant side effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the benefits of Angiotensin Receptor Blockers (ARBs)?

A

Decrease mortality, especially in patients with severe heart failure

ARBs are beneficial for patients who cannot tolerate ACEI due to cough.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the expected effect of loop diuretics in heart failure treatment?

A
  • Increased salt and water excretion
  • Reduced preload and afterload
  • Reduced pulmonary and peripheral edema

Furosemide is a common loop diuretic used for acute and chronic heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the role of Aldosterone Antagonists in heart failure treatment?

A

Competitive blockade of aldosterone receptor, reducing morbidity and mortality

Examples include Spironolactone and Eplerenone; adverse effects include hyperkalemia and leg cramps.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the main action of beta-adrenergic receptor blockers in heart failure?

A

Inhibits cardiotoxicity of catecholamines, decreases neurohumoral activation, and decreases heart rate

Examples include Metoprolol, Carvedilol, and Bisoprolol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the new first-line drug for HFrEF?

A

Valsartan + sacubitril combination (ARNI)

Valsartan is an Angiotensin 1 inhibitor; sacubitril is a neprilysin inhibitor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the adverse effects of Digoxin?

A
  • GI effects
  • Anorexia
  • Nausea and vomiting
  • Diarrhea
  • Disorientation and hallucinations
  • Visual disturbances
  • Cardiac arrhythmias

Digoxin has a low therapeutic index and requires careful monitoring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False: SGLT2 inhibitors can be used in heart failure management regardless of diabetic status.

A

True

They have shown decreased risk of worsening heart failure and mortality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fill in the blank: The primary compensatory response in heart failure is _______.

A

Prolonged sympathetic activation

This leads to various adverse remodeling effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the effect of elevated Angiotensin II in heart failure?

A
  • Sodium retention
  • Water retention
  • Adverse remodeling of heart and blood vessels

This contributes to the progression of heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the effect of an efferent tone on the heart?

A

Facilitates muscarinic transmission at heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the role of beta-adrenoceptor agonists?

A

Stimulation of adenylyl cyclase increases cAMP

20
Q

What does cAMP activate?

A

cAMP-dependent protein kinase

21
Q

What is the effect of protein kinase on L-type channels?

A

Increases Ca++ influx

22
Q

What is Dobutamine used for?

A

Acute treatment of decompensated heart failure

23
Q

What type of agonist is Dobutamine?

A

Beta-1-adrenoceptor selective agonist

24
Q

What is the positive effect of Dobutamine?

A

Increases cardiac output (CO)

25
What are the clinical applications of Dobutamine?
* Acute decompensated heart failure * Intermittent therapy in chronic heart failure to reduce symptoms
26
What is the major toxicity associated with Dobutamine?
Arrhythmias
27
What does Dopamine do at lower doses?
Vasodilation by stimulating dopamine receptors
28
What are the clinical applications of Dopamine?
* Acute decompensated heart failure * Shock
29
What is the major toxicity associated with Dopamine?
Arrhythmias
30
What type of inhibitor is Milrinone?
Phosphodiesterase type 3 inhibitor
31
What does Milrinone increase?
cAMP levels
32
What are the clinical applications of Milrinone?
* Acute decompensated heart failure * Intermittent therapy in chronic heart failure to reduce symptoms
33
What is the major toxicity associated with Milrinone?
Arrhythmias
34
What does Ivabradine block?
I_f (funny channel); hyperpolarization-activated cyclic nucleotide-gated channel (HCN); pacemaker channels
35
What is the effect of Ivabradine on heart rate?
Decreases heart rate
36
What is the effect of Ivabradine on contractility?
No effect on contractility
37
What are the criteria for Ivabradine approval?
* Stable, symptomatic heart failure * EF 35% * Normal sinus rhythm * HR ≥ 70 bpm * Beta-blocker at max dose or cannot be used
38
What is a key benefit of Ivabradine?
Reduces risk of hospitalization for worsening heart failure
39
What are the adverse effects of Ivabradine?
* Bradycardia * Atrial fibrillation * Hypertension * Visual disturbances
40
What should be prescribed post-MI for asymptomatic patients with EF < 50%?
ACE inhibitors (ACEi)
41
What is recommended for early stage management of heart failure?
Lifestyle changes
42
Firstline drug for HFrEF
Valsartan + saculbitril combination (ARNi) ## Footnote Sacubitril = proANP/proBNP degradation inhibitor (neprilysin inhibitor)
43
Dapagliflozin
Sodium-glucose transporter inhibitor - improves outcomes in HFrEF (promising results in HFpEF trials) ## Footnote Decreased fluid and glucose induced oxidative stress on heart (reduced remodeling)
44
Hydralazine
Selective arteriole dilator
45
Digoxin
Positive inotropic ## Footnote Digitalis - cardiac glycoside
46
Your 48 year old, Type I diabetic patient was recently diagnosed with systolic heart failure. Which of the following would be the best first choice drug in this patient
Lisinopril ## Footnote Can precipitate DKA with dapaglifloxin in type I diabetes - only used in type II
47
MOA of dobutamine
Beta-one agonist